{"nct_id":"NCT02352948","title":"A Global Study to Assess the Effects of MEDI4736 (Durvalumab), Given as Monotherapy or in Combination With Tremelimumab Determined by PD-L1 Expression Versus Standard of Care in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer","status":"COMPLETED","status_verified_date":"2024-07","start_date":"2015-01-13","start_date_type":"ACTUAL","primary_completion_date":"2018-02-09","primary_completion_date_type":"ACTUAL","completion_date":"2023-08-30","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["AZN"]}